UK markets close in 5 hours 10 minutes

Zevra Therapeutics, Inc. (1GDA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.6200-0.1000 (-2.12%)
As of 08:04AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,563
10,458
28,650
13,288
Cost of revenue
1,089
343
2,059
1,305
Gross profit
15,474
10,115
26,591
11,983
Operating expenses
Research development
34,926
19,614
10,161
8,843
Selling general and administrative
24,734
15,343
8,701
7,921
Total operating expenses
59,660
34,957
18,862
16,764
Operating income or loss
-44,186
-24,842
7,729
-4,781
Interest expense
915
335
376
7,090
Total other income/expenses net
541
-17,912
-16,135
-1,012
Income before tax
-39,951
-42,329
-8,521
-12,794
Income tax expense
-34
-786
34
-34
Income from continuing operations
-39,917
-41,543
-8,555
-12,760
Net income
-39,917
-41,543
-8,555
-12,760
Net income available to common shareholders
-39,917
-41,543
-62,897
-12,760
Basic EPS
-1.16
-1.20
-2.11
-3.21
Diluted EPS
-1.16
-1.20
-2.11
-3.21
Basic average shares
34,400
34,489
29,766
3,981
Diluted average shares
36,212
34,489
29,766
3,981